Drug Therapy for AUD May Cut Risk for Alcohol-Related Liver Disease
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis
Data showed a significant effect on abstinence rates with the use of baclofen (odds ratio [OR] 2.67, 95% CI: 1.03, 6.93) but no other significant effects on treatment efficacy (heavy drinking days SMD -0.26, 95% CI: -0.68, 0.15) or mechanism of action (craving SMD: -0.13, 95% CI: -0.36, 0.09) were seen.
Telltale signs of chronic alcohol use are large drops in plasma phosphate, magnesium, potassium, calcium
Previous literature had suggested that moderate alcohol consumption may prevent heart attack and congestive heart failure.
Especially among young drivers; analysis shows device would be cost-effective in all new U.S. cars
Findings in patients with head and neck cancer undergoing prophylactic GT insertion